tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
KYKOF Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsKYKOF Upcoming Earnings Report: What to Expect?
1M ago
Kyowa Kirin to regain control of rocatinlimab development, commercialization
Premium
The Fly
Kyowa Kirin to regain control of rocatinlimab development, commercialization
2M ago
Kyowa Kirin downgraded to Sell from Neutral at Goldman Sachs
Premium
The Fly
Kyowa Kirin downgraded to Sell from Neutral at Goldman Sachs
3M ago
Is KYKOF a Buy, Before Earnings?
PremiumPre-EarningsIs KYKOF a Buy, Before Earnings?
1y ago
Nvidia reports Q3 beat, Starbucks explores China partnerships: Morning Buzz
Premium
The Fly
Nvidia reports Q3 beat, Starbucks explores China partnerships: Morning Buzz
1y ago
Kura Oncology price target lowered to $18 from $22 at Scotiabank
Premium
The Fly
Kura Oncology price target lowered to $18 from $22 at Scotiabank
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100